Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

BOHS Announces Eleventh Inhaled Particles Symposium

Published: Monday, March 04, 2013
Last Updated: Sunday, March 03, 2013
Bookmark and Share
Symposium will be held in the city of Nottingham from 23 to 25 September 2013.

The British Occupational Hygiene Society (BOHS) has announced its latest Inhaled Particles symposium, the eleventh in a long line of highly successful and prestigious conferences, to be held in the city of Nottingham from 23 to 25 September 2013.

The first Inhaled Particles symposium was held at Oxford University in 1960, making the meetings the oldest ongoing international symposium series on the health effects of particles.

Over the intervening fifty years, the ten Inhaled Particles meetings have witnessed all of the key developments in occupational and public health associated with airborne particles.

In particular, the Inhaled Particles symposia have been distinguished by an integrative approach to the science of particle-mediated lung disease, involving exposure scientists, epidemiologists, toxicologists and others concerned about the harm caused by inhaling particles.

The early symposia were important in helping establish standards for dust control in coalmines in the UK and other countries, reducing the incidence of pneumoconiosis among miners.

By the 1980s and 1990s, the main emphasis had shifted to fibres, including asbestos.

Inhaled Particles XI (IPXI), to be held at Nottingham Conference Centre, at Nottingham Trent University, will take a multi-disciplinary approach, addressing topics within:
• exposure, for example controls, instrumentation and measurement
• hazards, including deposition, clearance, particokinetics, toxicology, and mechanisms of disease
• risk assessment, for example epidemiology, health impacts and links with policy.

BOHS is inviting all researchers who work on exposure, metrology, epidemiology, toxicology and risk assessment in particle-associated diseases to attend the latest meeting.

In addition, BOHS continues to invite authors to submit abstracts for oral or poster presentations. All abstracts must be submitted no later than 8 April 2013. Authors will be notified by 10 May 2013.

Key speakers will include the following.
• Dr Michael Attfield is a senior epidemiologist and expert on coal miner health. He acted as co-director in a major project to examine the relationship between lung cancer and exposure to diesel exhaust. The findings of this project led to the determination by the International Agency for Research on Cancer (IARC) that there was sufficient evidence that diesel exhaust particulate was a human carcinogen.
• Dr Derk Brouwer is a senior scientist in exposure assessment with the Dutch Organization for Applied Scientific Research TNO in the Netherlands. He is active in a wide range of international projects on assessment of worker exposure to nanoparticles. In particular his research focuses on measurement strategies and exposure modeling issues.
• Dr Vince Castranova is the Chief of the Pathology and Physiology Research Branch at the National Institute for Occupational Safety and Health (NIOSH) in Morgantown, West Virginia. His research interests have been concentrated in pulmonary toxicology and occupational lung disease. He has been coordinator of the Nanotoxicology Program in NIOSH since its inception in 2005.
• Dave Litton, a Senior Research Physicist at NIOSH in Pittsburgh, Pennsylvania, is an expert in fire detection, flame spectroscopy and optical diagnostics as well as in the measurement of combustion-generated particulate matter. For the past 12 to 15 years his research has been divided between managing combustion projects related to fire and explosion safety, and new approaches to atmospheric dusts and aerosols.

Commenting on the plans for September 2013, Professor Ken Donaldson, Chair of the IPXI Scientific Committee, said “IPXI will seek to continue its fine tradition of over fifty years, bringing together leading researchers on the adverse effects of particles on the lungs and extra-pulmonary target tissues to showcase cutting edge research and debate solutions to the challenges faced within particle research and risk assessment”.

Further information about the event, including booking forms, can be accessed at Delegates who book before 1 July 2013 will receive an “early bird” discounted rate of £540.00.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Editing Gene Mutations in Anemia
Researchers successfully use a new gene editing strategy to correct mutations that cause a form of anemia.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Observing Direct Inheritance of Gene-Silencing RNA
Research has allowed for the observation of double-stranded RNA molecule being passed from parent to offspring in roundworms.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
Nanoparticles Offer Promising Platform for Flavivirus Treatment
New nanoparticle effectively vaccinated mice against one dengue strain and could be created to target all four.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Ovarian Cancer Insight
Study showed tumours release cytokines to attract macrophages, which secrete growth factors that in turn promote tumour growth.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos